Your browser doesn't support javascript.
loading
Time for a regulatory framework for pediatric medications in Canada.
Gilpin, Andrea; Bérubé, Sophie; Moore-Hepburn, Charlotte; Lacaze-Masmonteil, Thierry; Samiee-Zafarghandy, Samira; Rieder, Michael; Gruenwoldt, Emily; MacLeod, Stuart; Litalien, Catherine.
Affiliation
  • Gilpin A; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • Bérubé S; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • Moore-Hepburn C; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • Lacaze-Masmonteil T; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • Samiee-Zafarghandy S; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • Rieder M; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • Gruenwoldt E; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • MacLeod S; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
  • Litalien C; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University
CMAJ ; 194(19): E678-E680, 2022 05 16.
Article in En | MEDLINE | ID: mdl-35577378
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval Limits: Child / Humans Country/Region as subject: America do norte Language: En Journal: CMAJ Journal subject: MEDICINA Year: 2022 Document type: Article Country of publication: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval Limits: Child / Humans Country/Region as subject: America do norte Language: En Journal: CMAJ Journal subject: MEDICINA Year: 2022 Document type: Article Country of publication: Canada